Xiaofeng Fan

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Xiao-feng Fan, Xiaofen Fan
Publication record
75 papers · 2,413 citations · H-index 28

PAPERS

Corrigendum to "Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury." Kidney Int. 2022;101:79-91.
20230 citationsauthor #10
Epidermal growth factor receptor activation is essential for kidney fibrosis development
202336 citationsauthor #12
Corrigendum to "Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury." Kidney Int. 2022;101:79-91.
20230 citationsauthor #10
Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice
202239 citationsauthor #8
Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis
202210 citationsauthor #8
Kir4.2 mediates proximal potassium effects on glutaminase activity and kidney injury
202214 citationsauthor #6
EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance
202253 citationsauthor #9
Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation
202155 citationsauthor #9
Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq
202119 citationsauthor #7
Mice with a Deficient Myeloid COX-2/EP4 Axis Developed More Severe Kidney Dysfunction in Response to a High-Fat Diet
20210 citationsauthor #6
COX-2-EP4-MafB Axis Protects Against Renal Fibrosis in Mice with Renal Ischemic Injury
20210 citationsauthor #8
Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction.
202113 citationsauthor #6
Activation of EGFR in Myofibroblasts Promotes Renal Fibrosis in Unilateral Ureteral Obstruction
20210 citationsauthor #6
Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.
202125 citationsauthor #9
A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion
20200 citationsauthor #4
Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy
202063 citationsauthor #7
Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy
20203 citationsauthor #5
In-depth serum virome analysis in patients with acute liver failure with indeterminate etiology
20195 citationsauthor #5
The Role of the EGF Receptor in Sex Differences in Kidney Injury.
201930 citationsauthor #10
Full annotation of serum virome in Chinese blood donors with elevated alanine aminotransferase levels
201916 citationsauthor #6
Circular RNA Profiling by Illumina Sequencing via Template-Dependent Multiple Displacement Amplification
201917 citationsauthor #7
Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes
201876 citationsauthor #6
TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration.
2018100 citationsauthor #7
Mechanisms of inhibiting human leukemia cell lines by serum of rats treated with compound banmao capsule
20172 citationsauthor #4
Interpatient mutational spectrum of human coronavirus‐OC43 revealed by illumina sequencing
20177 citationsauthor #3
Template-dependent multiple displacement amplification for profiling human circulating RNA.
201721 citationsauthor #7
Evidence for deleterious hepatitis C virus quasispecies mutation loads that differentiate the response patterns in IFN-based antiviral therapy.
20163 citationsauthor #6
Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy
201677 citationsauthor #4
Effect of Dioscorea tokoro Makino extract on hyperuricemia in mice
20164 citationsauthor #3
Telomerase deficiency delays renal recovery in mice after ischemia reperfusion injury by impairing autophagy
201583 citationsauthor #2
Patterns of longitudinal change in hepatitis C virus neutralization titers correlate with the outcome of peginterferon and ribavirin combination therapy
20150 citationsauthor #5
Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension.
201573 citationsauthor #6
Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
201537 citationsauthor #4
High-Resolution Quantification of Hepatitis C Virus Genome-Wide Mutation Load and Its Correlation with the Outcome of Peginterferon-Alpha2a and Ribavirin Combination Therapy
201419 citationsauthor #6
Comprehensive cloning of patient-derived 9022-bp amplicons of hepatitis C virus.
20133 citationsauthor #4
Low nitric oxide bioavailability up-regulates renal heparin binding EGF-like growth factor expression
201332 citationsauthor #4
Viral categorization and discovery in human circulation by transcriptome sequencing.
20134 citationsauthor #5
Epithelial-Specific Deletion of 11β-HSD2 Hinders Apcmin/+ Mouse Tumorigenesis
201314 citationsauthor #4
CSF-1 signaling mediates recovery from acute kidney injury.
2012310 citationsauthor #6
Intrarenal Dopamine Inhibits Progression of Diabetic Nephropathy
201237 citationsauthor #6
Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice
201273 citationsauthor #3
Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
201246 citationsauthor #5
Divergent quasispecies evolution in de novo hepatitis C virus infection associated with bone marrow transplantation.
20114 citationsauthor #6
Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics
201112 citationsauthor #4
The Core/E1 domain of hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma.
20115 citationsauthor #10
Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.
201185 citationsauthor #2
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
2011116 citationsauthor #4
RT-PCR amplification and cloning of large viral sequences.
20109 citationsauthor #1
Enhanced protocol for determining the 3' terminus of hepatitis C virus.
20102 citationsauthor #2
Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt
200922 citationsauthor #2
Mutations in the Hepatitis C Virus core Gene Are Associated with Advanced Liver Disease and Hepatocellular Carcinoma
200977 citationsauthor #4
High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy
200949 citationsauthor #1
Distinct roles for basal and induced COX-2 in podocyte injury.
200951 citationsauthor #2
Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy
200854 citationsauthor #3
Comparative Analysis of Nearly Full-Length Hepatitis C Virus Quasispecies from Patients Experiencing Viral Breakthrough during Antiviral Therapy: Clustered Mutations in Three Functional Genes, E2, NS2, and NS5a
200825 citationsauthor #2
Characterization of a putative intrarenal serotonergic system.
200728 citationsauthor #3
Overexpression of cyclooxygenase-2 predisposes to podocyte injury.
200776 citationsauthor #6
Separation of near full-length hepatitis C virus quasispecies variants from a complex population.
200715 citationsauthor #2
Efficient amplification and cloning of near full-length hepatitis C virus genome from clinical samples
200619 citationsauthor #1
Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: The null responder
200625 citationsauthor #2
Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection
200593 citationsauthor #2
[Hepatitis c virus genotype research by ABC programs of 5'-NCR restriction endonuclease digestion].
20042 citationsauthor #5
Binding Regions of Hepatitis C Virus Remain Conserved After Liver Transplantation
20040 citationsauthor #2
CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
20041 citationsauthor #2
Hepatitis c virus genotype research by ABC programs of 5'-NCR restriction endocuclease digestion
20043 citationsauthor #5
HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
200471 citationsauthor #3
Liver transplantation with hepatitis C virus‐infected graft: Interaction between donor and recipient viral strains
200331 citationsauthor #1
Diversification of hypervariable region 1 of hepatitis C virus after liver transplantation
20037 citationsauthor #1
Compartmentalization of hepatitis C viral quasispecies
20031 citationsauthor #1
Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis
20022 citationsauthor #1
Direct evidence for GB virus C/hepatitis G virus (GBV‐C/HGV) superinfection: Elimination of resident viral strain by donor strain in a patient undergoing liver transplantation
20027 citationsauthor #1
Expression of c-myc Promoter Binding Protein (MBP-1), a Novel Eukaryotic Repressor Gene, in Cirrhosis and Human Hepatocellular Carcinoma
20016 citationsauthor #1
Evolution of hepatitis C viral quasispecies after liver transplantation.
200164 citationsauthor #2
Comparison of genetic heterogeneity of hepatitis C viral RNA in liver tissue and serum
199922 citationsauthor #1
Comparison of genetic heterogeneity of hepatitis C viral RNA in liver tissue and serum.
199910 citationsauthor #1

TIMELINE

1999 32 citations

2001 70 citations

2002 9 citations

2003 39 citations

2004 77 citations

2005 93 citations

2006 44 citations

2007 119 citations

2008 79 citations

2009 199 citations

2010 11 citations

2011 222 citations

2012 466 citations

2013 53 citations

2014 19 citations

2015 193 citations

2016 84 citations

2017 30 citations

2018 176 citations

2019 68 citations

2020 66 citations

2021 112 citations

2022 116 citations

2023 36 citations

COAUTHOR MAP

CONCEPT FOOTPRINT